CAMBIUM NETWORKS CORP (CMBM)

KYG177661090 - Common Stock

4.03  +0.09 (+2.28%)

Fundamental Rating

2

Overall CMBM gets a fundamental rating of 2 out of 10. We evaluated CMBM against 54 industry peers in the Communications Equipment industry. CMBM has a bad profitability rating. Also its financial health evaluation is rather negative. CMBM is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

In the past year CMBM has reported negative net income.
CMBM had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CMBM reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: CMBM reported negative operating cash flow in multiple years.

1.2 Ratios

CMBM has a Return On Assets of -27.71%. This is in the lower half of the industry: CMBM underperforms 77.78% of its industry peers.
CMBM has a worse Return On Equity (-67.07%) than 77.78% of its industry peers.
Industry RankSector Rank
ROA -27.71%
ROE -67.07%
ROIC N/A
ROA(3y)-1.37%
ROA(5y)-1.06%
ROE(3y)-6.61%
ROE(5y)-6.92%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CMBM has a worse Gross Margin (32.30%) than 66.67% of its industry peers.
In the last couple of years the Gross Margin of CMBM has declined.
CMBM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.58%
GM growth 5Y-7.52%

2

2. Health

2.1 Basic Checks

CMBM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CMBM has more shares outstanding
The number of shares outstanding for CMBM has been increased compared to 5 years ago.
CMBM has a worse debt/assets ratio than last year.

2.2 Solvency

CMBM has an Altman-Z score of 0.67. This is a bad value and indicates that CMBM is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.67, CMBM perfoms like the industry average, outperforming 46.30% of the companies in the same industry.
A Debt/Equity ratio of 0.23 indicates that CMBM is not too dependend on debt financing.
CMBM's Debt to Equity ratio of 0.23 is in line compared to the rest of the industry. CMBM outperforms 46.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z 0.67
ROIC/WACCN/A
WACC9.35%

2.3 Liquidity

CMBM has a Current Ratio of 1.73. This is a normal value and indicates that CMBM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.73, CMBM is in line with its industry, outperforming 42.59% of the companies in the same industry.
A Quick Ratio of 1.02 indicates that CMBM should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.02, CMBM is not doing good in the industry: 68.52% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.02

3

3. Growth

3.1 Past

The earnings per share for CMBM have decreased strongly by -217.89% in the last year.
Looking at the last year, CMBM shows a very negative growth in Revenue. The Revenue has decreased by -25.84% in the last year.
Measured over the past years, CMBM shows a decrease in Revenue. The Revenue has been decreasing by -1.85% on average per year.
EPS 1Y (TTM)-217.89%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-363.89%
Revenue 1Y (TTM)-25.84%
Revenue growth 3Y-7.53%
Revenue growth 5Y-1.85%
Revenue growth Q2Q-52.42%

3.2 Future

Based on estimates for the next years, CMBM will show a very strong growth in Earnings Per Share. The EPS will grow by 41.73% on average per year.
CMBM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.74% yearly.
EPS Next Y77.38%
EPS Next 2Y55.12%
EPS Next 3Y41.73%
EPS Next 5YN/A
Revenue Next Year2.33%
Revenue Next 2Y11.44%
Revenue Next 3Y9.74%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CMBM. In the last year negative earnings were reported.
Also next year CMBM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as CMBM's earnings are expected to grow with 41.73% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.12%
EPS Next 3Y41.73%

0

5. Dividend

5.1 Amount

CMBM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CAMBIUM NETWORKS CORP

NASDAQ:CMBM (5/7/2024, 11:06:34 AM)

4.03

+0.09 (+2.28%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap112.40M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.71%
ROE -67.07%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 32.3%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.73
Quick Ratio 1.02
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-217.89%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y77.38%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-25.84%
Revenue growth 3Y-7.53%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y